Market Research Logo

INSYS Therapeutics, Inc. - Product Pipeline Review - 2016

INSYS Therapeutics, Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘INSYS Therapeutics, Inc. - Product Pipeline Review - 2016’, provides an overview of the INSYS Therapeutics, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by INSYS Therapeutics, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of INSYS Therapeutics, Inc.
  • The report provides overview of INSYS Therapeutics, Inc. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses INSYS Therapeutics, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features INSYS Therapeutics, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate INSYS Therapeutics, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for INSYS Therapeutics, Inc.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding INSYS Therapeutics, Inc.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


INSYS Therapeutics, Inc. Snapshot
INSYS Therapeutics, Inc. Overview
Key Information
Key Facts
INSYS Therapeutics, Inc. - Research and Development Overview
Key Therapeutic Areas
INSYS Therapeutics, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
INSYS Therapeutics, Inc. - Pipeline Products Glance
INSYS Therapeutics, Inc. - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
INSYS Therapeutics, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
INSYS Therapeutics, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
INSYS Therapeutics, Inc. - Drug Profiles
dronabinol
Product Description
Mechanism of Action
R&D Progress
buprenorphine hydrochloride
Product Description
Mechanism of Action
R&D Progress
Cannabidiol
Product Description
Mechanism of Action
R&D Progress
(buprenorphine hydrochloride + naloxone hydrochloride)
Product Description
Mechanism of Action
R&D Progress
naloxone hydrochloride
Product Description
Mechanism of Action
R&D Progress
ondansetron hydrochloride
Product Description
Mechanism of Action
R&D Progress
paclitaxel
Product Description
Mechanism of Action
R&D Progress
cetirizine hydrochloride + cromolyn sodium
Product Description
Mechanism of Action
R&D Progress
diclofenac sodium
Product Description
Mechanism of Action
R&D Progress
ketorolac tromethamine
Product Description
Mechanism of Action
R&D Progress
sildenafil citrate
Product Description
Mechanism of Action
R&D Progress
INSYS Therapeutics, Inc. - Pipeline Analysis
INSYS Therapeutics, Inc. - Pipeline Products by Target
INSYS Therapeutics, Inc. - Pipeline Products by Route of Administration
INSYS Therapeutics, Inc. - Pipeline Products by Molecule Type
INSYS Therapeutics, Inc. - Pipeline Products by Mechanism of Action
INSYS Therapeutics, Inc. - Recent Pipeline Updates
INSYS Therapeutics, Inc. - Dormant Projects
INSYS Therapeutics, Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
Monoclonal Antibody Conjugate to Target Mesothelin for Oncology
INSYS Therapeutics, Inc. - Company Statement
INSYS Therapeutics, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
INSYS Therapeutics, Inc., Key Information
INSYS Therapeutics, Inc., Key Facts
INSYS Therapeutics, Inc. - Pipeline by Indication, 2016
INSYS Therapeutics, Inc. - Pipeline by Stage of Development, 2016
INSYS Therapeutics, Inc. - Monotherapy Products in Pipeline, 2016
INSYS Therapeutics, Inc. - Combination Treatment Modalities in Pipeline, 2016
INSYS Therapeutics, Inc. - Pre-Registration, 2016
INSYS Therapeutics, Inc. - Phase III, 2016
INSYS Therapeutics, Inc. - Phase II, 2016
INSYS Therapeutics, Inc. - Phase I, 2016
INSYS Therapeutics, Inc. - Preclinical, 2016
INSYS Therapeutics, Inc. - Pipeline by Target, 2016
INSYS Therapeutics, Inc. - Pipeline by Route of Administration, 2016
INSYS Therapeutics, Inc. - Pipeline by Molecule Type, 2016
INSYS Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2016
INSYS Therapeutics, Inc. - Recent Pipeline Updates, 2016
INSYS Therapeutics, Inc. - Dormant Developmental Projects,2016
INSYS Therapeutics, Inc. - Discontinued Pipeline Products, 2016
INSYS Therapeutics, Inc., Other Locations
INSYS Therapeutics, Inc., Subsidiaries
List of Figures
INSYS Therapeutics, Inc. - Pipeline by Top
INSYS Therapeutics, Inc. - Pipeline by Stage of Development,
INSYS Therapeutics, Inc. - Monotherapy Products in Pipeline,
INSYS Therapeutics, Inc. - Combination Treatment Modalities in Pipeline,
INSYS Therapeutics, Inc. - Pipeline by Top
INSYS Therapeutics, Inc. - Pipeline by Route of Administration,
INSYS Therapeutics, Inc. - Pipeline by Molecule Type,
INSYS Therapeutics, Inc. - Pipeline Products by Top

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report